ANVS logo

ANVS
Annovis Bio Inc

9,835
Mkt Cap
$74.49M
Volume
808,073.00
52W High
$5.50
52W Low
$1.54
PE Ratio
-1.25
ANVS Fundamentals
Price
$2.35
Prev Close
$2.15
Open
$2.24
50D MA
$2.13
Beta
1.69
Avg. Volume
1.38M
EPS (Annual)
-$1.40
P/B
19.63
Rev/Employee
$0.00
$51.58
Loading...
Loading...

About

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. The company's product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. Annovis Bio was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8

Frequently Asked Questions

What is Market Cap of Annovis Bio Inc?
What is the 52-week high for Annovis Bio Inc?
What is the 52-week low for Annovis Bio Inc?
What is Annovis Bio Inc stock price today?
What was Annovis Bio Inc stock price yesterday?
What is the PE ratio of Annovis Bio Inc?
What is the Price-to-Book ratio of Annovis Bio Inc?
What is the 50-day moving average of Annovis Bio Inc?
How many employees does Annovis Bio Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available